No Data
CLSA Premium Limited Reports 2024 Financial Results and Strategic Changes
CLSA PREMIUM (06877) plans to rename itself as "Top Eminent Healthcare Group Limited".
CLSA PREMIUM (06877) announced that the Board of Directors recommends that Shareholders approve the company's name...
CLSA PREMIUM (06877) announced its performance for 2024 with a net profit of 11.338 million Hong Kong dollars, an increase of 15.2% year-on-year.
CLSA PREMIUM (06877) announced the 2024 performance, with total revenue of approximately 0.103 billion Hong Kong dollars...
Express News | CLSA Premium FY Net Income HKD 11.3 Million
CLSA PREMIUM: AUDITED RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024,PROPOSED CHANGE OF COMPANY NAME,PROPOSED AMENDMENTS TO THE MEMORANDUM ANDARTICLES OF ASSOCIATION ANDADOPTION OF THE AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
CLSA PREMIUM (06877.HK) plans to hold a Board of Directors meeting on March 17 to approve the annual performance.
Gelonghui reported on February 28 that CLSA PREMIUM (06877.HK) announced that the Board of Directors meeting will be held on March 17, 2025 (Monday), to approve the full-year performance of the company and its subsidiaries for the year ending December 31, 2024, and its release, as well as to consider the proposed distribution of the final dividend (if any).
